Searched for
NEW VACCINE POLICY
Fable 5 shock puts sovereign AI back on India’s agendaUS export controls on advanced AI models have spurred India's call for sovereign AI development. Industry leaders warn against reliance on ...- India sends measles vaccines, medical supplies to Maldives amid rising casesIndia has provided 20,000 measles vaccine doses and three tonnes of medical supplies to the Maldives. This assistance aims to address incre...
- To win the deep-tech race, India needs ‘General Innovation Rules’India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...
- Science at scale: India’s journey from food security to global leadershipToday, India is the world’s largest producer of milk, pulses, and spices; the largest exporter of rice; and among the leading producers of ...
- Maternity cover in group health insurance plans: Why outdated limits leave employees paying more out of pocketOne of the biggest advantages of a group policy is the waiver of the maternity waiting period. In individual policies, maternity typically ...
- India's 7.7 pc GDP growth in FY26 shows foundation of economy is strong, says PM ModiIndia's economy shows a strong foundation with 7.7 percent GDP growth for fiscal 2025-26. Prime Minister Narendra Modi stated India is the ...
- Rare earth, gas supply, aircraft parts: What’s inside the new IIP calculus as India revises base yearIndia is updating its Index of Industrial Production. The new series will use 2022-23 as the base year, replacing the old 2011-12 base. Thi...
- Pain for Pakistan: History makes a U-turn in India's neighbourhoodRussia and the Taliban have signed a significant military cooperation agreement. This pact alters regional security dynamics. Pakistan's st...
- 90.6% hospital births, 96% plus vaccinations: NFHS-6 reflects India's "accelerated progress" in family health parametersIndia's National Family Health Survey-6 shows significant improvements in maternal and child health. Vaccinations and antenatal care have i...
- Govt health spending triples to Rs 3.85 lakh crore in 2022-23: National Health AccountsGovernment spending on healthcare has surged to Rs 3.85 lakh crore in 2022-23, nearly tripling from a decade ago. This increased public inv...
- Is Quad the Asian NATO or ocean foam? What Delhi meet revealsQuad foreign ministers met in Delhi focusing on practical cooperation. New initiatives target critical minerals, maritime surveillance, and...
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Louisiana primary election results, winners: Can sitting Republican Senator Bill Cassidy win against Donald Trump-backed candidate Julia Letlow?Bill Cassidy Louisiana primary election results: Republican Senator's vote in favor of convicting Donald Trump after his 2021 impeachment o...
- Vivek Ramaswamy wins Republican nomination for Ohio governor after Trump's endorsementOhio voters have chosen their candidates for key November elections. Billionaire Vivek Ramaswamy will face Dr. Amy Acton for governor. Sena...
- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- AstraZeneca plans to invest $405 million in Britain, PM Keir Starmer saysPrime Minister Keir Starmer announced AstraZeneca will invest 300 million pounds in UK life sciences. This significant investment secures 1...
- ET Awards: DLF chairman emeritus Kushal Pal Singh calls for long-term urbanisation reforms to drive India’s growthKushal Pal Singh, DLF chairman emeritus, urges India to adopt a bold, long-term urbanisation strategy. He believes radical reforms are vita...
Load More
